がん治療・がん免疫療法「癌樹状細胞療法」のセレンクリニック／リンク集

1.�Schott M, et al. Dendritic cell immunotherapy induces antitumour response in parathyroid carcinoma and neuroendocrine pancreas carcinoma. Horm Metab Res. 1999, 31: 662-664.

2. Morse M, et al. A phase 1 study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic cultured dendritic cells in patients with metastatic malignancies expres

3.� Schott M, et al. Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma. Clin Endocrinol (Oxf). 2001, 55: 271-277.

4. Pecher G, et al. Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial. Cancer Immunol Immunother. 2002, 8 (11-12): 669-73.

5.�Iwashita Y, et al. A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. Cancer Immunology Immunotherapy. 2003, 52: 155-161.

6.�Chi KH, et al. Combination of conformal radiotherpay and intratumoural injection of adoptive dendritic cell immunotherapy in refractory hepatoma. Journal of Immunotherapy, 2005, 28 (2): 129-135.

7. Mazzolini G, Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas. J Clin Oncol. 2005, 23(5): 999-1010.

8. Katano M, Combination therapy with tumor cell-pulsed dendritic cells and activated lymphocytes for patients with disseminated carcinomas. Anticancer Res. 2005, 25(6A): 3771-6.